Altre lingue Ascelia Pharma AB

Azioni

ACE

SE0010573113

Biotecnologia

Tempo differito Nasdaq Stockholm Altri mercati azionari 17:29:46 23/01/2026			Variaz. 5gg	Var. 1 gen.
2,985 ^SEK	+2,40%		-5,39%	-7,15%

21/01	Il Vice Amministratore Delegato e CFO di Ascelia Pharma si Dimette	MT
21/01	Julie Waras Brogren, CFO e Vice CEO di Ascelia Pharma, lascerà l'azienda	RE

Altre lingue

21/01	Ascelia Pharma Deputy CEO, CFO to Step Down
21/01	Ascelia Pharma CFO, Deputy CEO Julie Waras Brogren to leave
21/01	Ascelia Pharma Announces Deputy CEO Julie Waras Brogren to Leave the Company
21/01	Ascelia Pharma AB Announces Departure of Julie Waras Brogren as Deputy CEO
22/12	Nomination Committee Appointed for AGM 2026 in Ascelia Pharma AB
28/11	Change in Number of Shares and Votes in Ascelia Pharma AB
19/11	Ascelia Pharma Resolves on Conversion of Series C Shares into Ordinary Shares for Delivery to Participants in Incentive Program
17/11	FDA sets review date for Ascelia Pharma's Orviglance NDA for July 3
17/11	Ascelia Pharma's New Drug Application for Orviglance Accepted for US FDA Review
15/11	Ascelia Pharma Announces FDA Acceptance of Orviglance New Drug Application for Review
15/11	Ascelia Pharma AB Announces FDA Acceptance of Orvigance New Drug Application for Review
10/11	Ascelia Pharma AB Files New Patent Application for Orvigance
10/11	Ascelia Pharma (Q3 review) - Partnering in focus ahead
10/11	Ascelia Pharma files new patent application for Orviglance
10/11	Ascelia Pharma Files New Patent Application for Orviglance
05/11	Ascelia Pharma AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025
05/11	Ascelia Pharma: Final stretch, with PDUFA date as next milestone – Q3 review
05/11	Quarterly Report Q3 2025: Orviglance NDA Submitted to the FDA
03/11	Biotechnology Company Ascelia Pharma Appoints New CFO, COO
03/11	Ascelia Pharma: Management changes announced
03/11	Ascelia Pharma recruits Anton Hansson as CFO
03/11	Ascelia Pharma Announces Management Changes to Support Future Growth
03/11	Ascelia Pharma AB Announces Promotion of Jennie Wilborgsson as Chief Operating Officer
03/11	Ascelia Pharma AB Announces Appointment of Anton Hansson as Chief Financial Officer, Effective Around Late January 2026
30/09/25	Change in Number of Shares and Votes in Ascelia Pharma AB

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Trascrizioni Comunicati stampa Pubblicazioni ufficiali Altre lingue Articoli MarketScreener Analisi MarketScreener Idee di trading

Altre lingue Ascelia Pharma AB

Azioni

ACE

SE0010573113

Biotecnologia

Altre lingue

Filtri